Cardiotoxicity of Non-Anthracycline Cancer Chemotherapy Agents

Throughout the last decades, newly developed chemotherapeutic agents and immunotherapies that target signaling pathways have provided patients with better prognoses, improved their quality of life and increased survival rates, thus converting cancer to a stable chronic disease. However, non-anthracy...

Descripción completa

Detalles Bibliográficos
Autores principales: Briasoulis, Alexandros, Chasouraki, Angeliki, Sianis, Alexandros, Panagiotou, Nikolaos, Kourek, Christos, Ntalianis, Argyrios, Paraskevaidis, Ioannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953347/
https://www.ncbi.nlm.nih.gov/pubmed/35323614
http://dx.doi.org/10.3390/jcdd9030066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953347/
https://www.ncbi.nlm.nih.gov/pubmed/35323614
http://dx.doi.org/10.3390/jcdd9030066

Ejemplares similares